In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Professor Sir John Hardy
Chair, Molecular Biology of Neurological Disease
Department of Neurodegenerative Diseases University College London
London, UK
No relevant financial relationships have been reported at this time.
Faculty:
Marwan N. Sabbagh, MD, FAAN
Vice Chairman for Research
Professor of Neurology
Barrow Neurological Institute
Phoenix, AZ
Dr. Sabbagh has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Abbvie, Anavex, Cognito Therapeutics, Eisai, GSK, KeiferRx, Lilly, NeuroTherapia, Novo Nordisk, Prothena, Roche-Genentech, Signant Health, Synaptogenix
Ownership: Alzheon, Athira, Lighthouse Pharmaceuticals, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Reservoir Neuroscience, Seq BioMarque, TransDermix, uMethod Health, Versanum
Reviewers/Content Planners/Authors:
- Jennifer Brutsche has nothing to disclose.
- Andrea Mathis has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
- Tim Person has nothing to disclose.
- Canan Schumann, PharmD, PhD, has nothing to disclose.
- Rosanne Strauss, PharmD, has nothing to disclose.